MICHELE F SALVATORE

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Women's Health CREVE COEUR, MO NPI 1013289867

General Payments — all program years on this page

$1,419.95

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 59
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $556.65 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $282.6715
Education $273.983

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Astellas Pharma US Inc $320.696
Amgen Inc. $86.364
PFIZER INC. $53.203
Bayer HealthCare Pharmaceuticals Inc. $24.831
Exeltis, USA Inc. $23.731
CooperSurgical, Inc. $19.981
Almatica Pharma Inc. $14.171
ABBVIE INC. $13.691

By program year

Program yearAmountRecords
2021 $262.7716
2022 $219.9212
2023 $380.6113
2024 $556.6518

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086366131 Bayer Healthcare Pharmaceuticals Inc. $24.83 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108137107 ABBVIE INC. $13.69 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117372984 Amgen Inc. $19.01 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117372986 Amgen Inc. $24.52 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117372988 Amgen Inc. $17.65 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117372990 Amgen Inc. $25.18 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131645466 PFIZER INC. $18.52 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131645470 PFIZER INC. $18.52 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131952336 PFIZER INC. $16.16 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137615527 Almatica Pharma LLC $14.17 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139486846 Astellas Pharma US Inc $18.40 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139504915 Astellas Pharma US Inc $74.99 03/11/2024 Education Undisputed 01/23/2026 View at CMS
1139529732 Astellas Pharma US Inc $13.46 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139542076 Astellas Pharma US Inc $99.00 11/14/2024 Education Undisputed 01/23/2026 View at CMS
1139542114 Astellas Pharma US Inc $99.99 11/21/2024 Education Undisputed 01/23/2026 View at CMS
1139546793 Astellas Pharma US Inc $14.85 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150019075 Exeltis, USA Inc. $23.73 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150789455 CooperSurgical, Inc. $19.98 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.